🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts stated the demand for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for preparing or administering at home.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience.

Item Information and Costs

Within these communities, posts show black plastic parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to potentially serious medical dangers”.